Respiratory Pathogen Distribution During and After the COVID-19 Pandemic
Comparative Analysis of Respiratory Pathogens During and After the SARS-CoV-2 Pandemic: A Retrospective Multiplex PCR-Based Study
This retrospective observational study aims to evaluate changes in the prevalence and distribution of respiratory pathogens detected by multiplex respiratory polymerase chain reaction (PCR) testing during and after the SARS-CoV-2 pandemic. The study includes 537 patients presenting with respiratory infection symptoms at a tertiary care center. Patients were divided into pandemic-period and post-pandemic-period groups, and respiratory pathogen profiles were compared between the groups.
The study investigates the epidemiological impact of COVID-19-related public health measures on respiratory pathogen circulation patterns, including bacterial and viral respiratory infections. The findings may contribute to improved respiratory infection surveillance, diagnostic strategies, and post-pandemic public health preparedness.
研究概览
地位
详细说明
The COVID-19 pandemic significantly altered the epidemiology of respiratory infections worldwide. Non-pharmaceutical interventions (NPIs), including mask use, social distancing, travel restrictions, enhanced hygiene measures, and lockdown policies, were implemented primarily to reduce SARS-CoV-2 transmission. However, these interventions also affected the circulation patterns of other respiratory pathogens.
Several studies have demonstrated substantial reductions in influenza, respiratory syncytial virus (RSV), and other respiratory viral infections during periods of strict public health measures. Following the relaxation of these interventions, many regions experienced re-emergence and altered seasonal patterns of respiratory pathogens. Continuous surveillance of respiratory infections has therefore become increasingly important for both clinical management and public health preparedness.
This retrospective observational cohort study aims to evaluate changes in respiratory pathogen prevalence during and after the SARS-CoV-2 pandemic using multiplex respiratory PCR testing data obtained from patients presenting with respiratory infection symptoms at a tertiary care center. A total of 537 patients were included and categorized into pandemic-period and post-pandemic-period groups.
Demographic characteristics and multiplex PCR results were analyzed and compared between the groups. Respiratory pathogens evaluated in the study included bacterial and viral agents such as Streptococcus pneumoniae, Haemophilus influenzae, Influenza A/B, SARS-CoV-2, RSV, Rhinovirus, Bocavirus, Parainfluenza virus, Coronavirus, and Metapneumovirus.
The study aims to contribute to understanding the long-term epidemiological effects of the COVID-19 pandemic and associated public health measures on respiratory pathogen distribution. In addition, the findings may support future infection surveillance strategies, diagnostic approaches, and healthcare preparedness in post-pandemic periods.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Istanbul、土耳其(türkiye)、34768
- Hisar Intercontinental Hospital
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Adults and/or pediatric patients presenting with respiratory infection symptoms
- Patients who underwent multiplex respiratory PCR testing
- Patients with complete demographic and laboratory records
- Patients included during the defined pandemic or post-pandemic study periods
Exclusion Criteria:
- Incomplete laboratory or demographic data
- Duplicate test records from the same infection episode
- Invalid or inconclusive PCR results
- Patients without respiratory infection symptoms
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Pandemic Period Group
Patients presenting with respiratory infection symptoms who underwent multiplex respiratory PCR testing during the SARS-CoV-2 pandemic period.
|
|
Post-Pandemic Period Group
Patients presenting with respiratory infection symptoms who underwent multiplex respiratory PCR testing during the post-pandemic normalization period.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in the prevalence of respiratory pathogens between the pandemic and post-pandemic periods
大体时间:Retrospectively assessed at the time of respiratory PCR testing during the study periods. Pandemic period: March 2020 - May 2023 Post-pandemic period: June 2023 - December 202
|
The primary outcome is the difference in detection rates of respiratory pathogens identified by multiplex respiratory PCR testing between the SARS-CoV-2 pandemic period and the post-pandemic period.
|
Retrospectively assessed at the time of respiratory PCR testing during the study periods. Pandemic period: March 2020 - May 2023 Post-pandemic period: June 2023 - December 202
|
合作者和调查者
出版物和有用的链接
一般刊物
- Poole S, Brendish NJ, Clark TW. SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study. J Infect. 2020 Dec;81(6):966-972. doi: 10.1016/j.jinf.2020.11.010. Epub 2020 Nov 15.
- Bandeira TJPG, Oliveira ALS, Martins LFP, Matos RM, Santos SRNGD, Lopes MC, Sobreira RTP, Rocha HAL. Molecular detection of respiratory viruses: an observational study on respiratory co-infections in children and adults. Braz J Microbiol. 2025 Mar;56(1):537-543. doi: 10.1007/s42770-024-01581-x. Epub 2024 Dec 17.
- Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B. Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses. 2021 Jul;15(4):425-428. doi: 10.1111/irv.12853. Epub 2021 Apr 4.
- Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, Cohen C, Fry AM. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant. 2020 Dec;20(12):3681-3685. doi: 10.1111/ajt.16381.
- Yam SLS, Baguio JMJ, Chan RWY. Pediatric Respiratory Viral Infection. Viruses. 2024 May 6;16(5):733. doi: 10.3390/v16050733.
- Agca H, Akalin H, Saglik I, Hacimustafaoglu M, Celebi S, Ener B. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. J Infect Public Health. 2021 Sep;14(9):1186-1190. doi: 10.1016/j.jiph.2021.08.004. Epub 2021 Aug 8.
- Agha R, Avner JR. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021 Sep;148(3):e2021052089. doi: 10.1542/peds.2021-052089. Epub 2021 Jun 9. No abstract available.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- HHI-RP-PCR-2026-001
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.